![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Selux Phenotyping System Cleared for Antibiotic Susceptibility Testing
Selux Phenotyping System Cleared for Antibiotic Susceptibility Testing
January 24, 2023
The FDA has granted 510(k) clearance to Selux Diagnostics for its next-generation phenotyping (NGP) system, a rapid antibiotic susceptibility testing platform for gram-positive bacteria.
The NGP system has the potential to decrease overreliance on broad-spectrum antibiotics since results provide specific susceptibility, enabling clinicians to prescribe a targeted antibiotic for gram-positive bacteria such as Staphylococcus aureus.
The FDA is currently reviewing the company’s NGP system for assessing the antibiotic susceptibility of gram-negative bacteria.
Upcoming Events
-
21Oct